Clinical Trial Report

Evaluation of the Pharmacokinetics of Trazpiroben (TAK-906), a Peripherally Selective D2/D3 Dopamine Receptor Antagonist, in the Presence and Absence of Itraconazole, a Potent CYP 3A4 Inhibitor

Chen C, Zhang W, Bari M, Almansa C, Baratta M, Rosario M

Clinical Pharmacology: Advances and Applications 2021, 13:145-155

Published Date: 12 July 2021